Abstract
ADHD is a highly prevalent disease in childhood which often persists into adulthood, then co-occurring with common adult conditions. Especially for adult ADHD, little is known about the costs of ADHD and the additional costs of comorbid conditions. To determine medical costs of ADHD and costs of comorbidities (mood, anxiety and substance use disorders, obesity), including their co-occurrence rates, stratified by age and gender. Claims data from a German Statutory Health Insurance database with approximately four million member-records per year were analysed. A total of 25,300 prevalent ADHD patients were identified by means of an ICD-10 GM diagnosis of ADHD. A 1:1 age and gender adjusted reference group without ADHD diagnosis was randomly selected. Total health claims and health care costs related to ADHD were analysed, in addition to more targeted analyses of the occurrence and costs of pre-defined common comorbidities of, in particular, adult ADHD (SUD, mood and anxiety disorders, obesity). Outcomes were mean costs per patient and occurrence rates of comorbid conditions. Surplus costs of a comorbid condition in persons with ADHD relative to costs of this condition in persons without ADHD were calculated. Subgroup analyses wer...Continue Reading
References
Apr 2, 2005·Current Medical Research and Opinion·Howard G BirnbaumAndrine R Swensen
May 2, 2007·The British Journal of Psychiatry : the Journal of Mental Science·J FayyadR Jin
Jun 2, 2007·The American Journal of Psychiatry·Guilherme PolanczykLuis Augusto Rohde
Jan 30, 2009·Child and Adolescent Psychiatry and Mental Health·Peter M WehmeierAribert Rothenberger
Jun 10, 2010·Archives of Disease in Childhood·Naomi TaylorVal Harpin
Sep 8, 2010·BMC Psychiatry·Sandra J J KooijPhilip Asherson
Nov 5, 2011·BMC Psychiatry·Susan YoungDavid Coghill
Oct 10, 2013·Psychological Medicine·R C KesslerA M Zaslavsky
Dec 18, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Susanna N VisserStephen J Blumberg
Jan 23, 2014·Journal of Learning Disabilities·Bryan G CookKatie M Heinrich
Nov 4, 2016·Journal of Attention Disorders·Christian P JacobKlaus-Peter Lesch
Mar 25, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Natasha KhalifeAlina Rodriguez
Jun 20, 2014·BMJ : British Medical Journal·Qi ChenHenrik Larsson
Aug 28, 2014·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Zheng ChangHenrik Larsson
Sep 27, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Swaran P Singh, Helena Tuomainen
Nov 5, 2015·Pharmacoepidemiology and Drug Safety·Frank Andersohn, Jochen Walker
Dec 23, 2015·Health Economics Review·Mike KloraJ-Matthias Graf von der Schulenburg
Feb 18, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Sebastian BraunWolfgang Greiner
Apr 19, 2016·Biological Psychiatry·Zheng ChangHenrik Larsson
Sep 25, 2016·Journal of Attention Disorders·Johanne Telnes InstanesJan Haavik
Nov 21, 2016·Attention Deficit and Hyperactivity Disorders·John FayyadUNKNOWN WHO World Mental Health Survey Collaborators
Jan 27, 2017·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Jörg M FegertHarald J Freyberger
Apr 15, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Komal Gupte-SinghKenneth A Lawson
Aug 24, 2017·BMC Psychiatry·Martin A KatzmanLarry J Klassen
Nov 23, 2017·Neuroscience and Biobehavioral Reviews·Maite Ruiz-GoikoetxeaGonzalo Arrondo
Citations
Jun 5, 2020·Nordic Journal of Psychiatry·Annette BjörkNiclas Olofsson
Apr 9, 2020·Der Nervenarzt·Sarah Kittel-Schneider, Andreas Reif
Sep 8, 2020·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Tobias BanaschewskiAndreas Reif
Oct 2, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Berit LibutzkiAndreas Reif
Apr 9, 2020·Frontiers in Psychiatry·Nathalie Brunkhorst-KanaanOliver Grimm
Jun 27, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Alexandra Philipsen, Manfred Döpfner
Mar 3, 2020·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Ebba Du RietzHenrik Larsson
Jan 1, 2021·Frontiers in Psychiatry·Oliver GrimmAndreas Reif
Dec 29, 2020·Neuroscience and Biobehavioral Reviews·Jutta S MayerChristine M Freitag
Feb 9, 2021·PharmacoEconomics·Anindit ChhibberNathorn Chaiyakunapruk
Jan 31, 2021·Neuroscience and Biobehavioral Reviews·Carmen SchiweckAndreas Reif
Feb 8, 2021·Neuroscience and Biobehavioral Reviews·Stephen V FaraoneYufeng Wang
Mar 5, 2021·Neuropsychiatric Disease and Treatment·Miguel Garcia PimentaStefanie Enriquez-Geppert
Apr 16, 2021·CNS Drugs·Sepehr FarahbakhshianWilliam Spalding
Mar 23, 2021·Acta Psychiatrica Scandinavica·Miguel Garcia-ArgibayEbba Du Rietz
Jun 6, 2021·Neuroscience and Biobehavioral Reviews·Anka BernhardChristine M Freitag
Jul 16, 2021·Neuroscience and Biobehavioral Reviews·Mathias LudererAndreas Reif
Feb 3, 2022·European Archives of Psychiatry and Clinical Neuroscience·Jutta S MayerChristine M Freitag